Fatigue News and Research

RSS

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

Heart attack survivors may have a lower risk of Parkinson's disease

People who have had a heart attack may be slightly less likely than people in the general population to develop Parkinson's disease later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

16 Feb 2022

COVID-Somnia: the relationship between COVID-19 and insomnia

Researchers explored the links between COVID-19 and sleep disorders such as insomnia using a thorough literature review.

16 Feb 2022

Study describes sequelae presenting more than six months after COVID-19 in non-hospitalized young adults

A recent study described COVID-19 sequelae developed in non-hospitalized young adults more than six months after COVID-19 infection.

15 Feb 2022

How has telemedicine assisted COVID-19 patients?

In acknowledging the urgent need for managing outpatients, especially after hospital discharge, scientists have conducted a pilot telemonitoring program.

14 Feb 2022

Enhanced external counterpulsation therapy benefits long COVID-19 patients

In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest discomfort, after undergoing 15-35 hours of enhanced external counterpulsation (EECP) therapy.

14 Feb 2022

Study explores the social impact of COVID-19 symptoms among female long haulers

A new study analyzed the impact of long-COVID on women long haulers with respect to various aspects of their social life.

14 Feb 2022

Researchers identify autoantibody targets in COVID-19 patients

In a new study, researchers have been investigating auto-immune responses to natural human antigens in COVID-19 patients.

14 Feb 2022

Looking into the long-COVID brain

Neurological issues, ranging from memory lapses to trouble with attention, have been widely reported after recovery from severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection. Unfortunately, there is limited information about pathways to recovery after severe COVID hospitalization. Now, a prospective study of 4,491 patients hospitalized with COVID suggests neurological recovery can take at least a year. The study is currently available on the medRxiv* preprint while awaiting peer review.

13 Feb 2022

Study examines the viral dynamics of Hong Kong's four SARS-CoV-2 waves

Researchers evaluate the efficiency of COVID-19 elimination strategies implemented in Hong Kong.

13 Feb 2022

Only few oncology dietitians ask cancer patients about food insecurity, research finds

Although studies suggest that many cancer patients experience food insecurity, few oncology dietitians routinely ask them if they are having problems affording or obtaining food, new research has found.

12 Feb 2022

Hazards of persistent and new clinical sequelae caused by SARS-CoV-2 infection among elderly patients

A new study estimated the risk and hazards of persistent and new clinical sequelae of the SARS-CoV-2 infection among elderly patients (above 65 years or older) during the post-acute phase of the infection.

11 Feb 2022

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

A survey demonstrated that patients with systemic autoimmune rheumatic diseases commonly experience augmented disease severity and disrupted treatment regimens of disease-modifying antirheumatic drugs after acute COVID-19 course.

11 Feb 2022

KHN’s ‘What the Health?’: FDA takes center stage

The FDA is still lacking a Senate-confirmed leader, but the agency is at the center of several major policy battles. Lawmakers this year must renew the bill that authorizes drug companies to pay "user fees," which enable the agency to hire additional reviewers to speed the approval of drugs.

10 Feb 2022

Study: Almost a third of older adults infected with covid-19 develop new conditions

Almost a third (32 of every 100) of older adults infected with covid-19 in 2020 developed at least one new condition that required medical attention in the months after initial infection, 11 more than those who did not have covid-19, finds a US study published by The BMJ today.

10 Feb 2022

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals.

10 Feb 2022

UCI case report: Antihistamines may provide relief for people suffering from long COVID-19 symptoms

Antihistamines may provide relief for the millions of people suffering from the painful, debilitating symptoms of long COVID-19 that impair daily functioning.

9 Feb 2022

Danish study of long COVID in teens

As an aftermath of the extended lockdowns and social distancing restrictions, Coronavirus disease 2019 (COVID-19) has impacted the quality of life of children and adolescents worldwide, not only physically due to the infection, but also mentally. A high level of anxiety and depression has been reported among pediatric patients and adolescents, many of whom were deprived of social interaction with peers during the pandemic.

9 Feb 2022

Toxic goiter affects the brain more than previously thought

Toxic goiter affects the brain more than was previously known, a University of Gothenburg study shows, and involves volume changes occurring in central parts of the brain.

8 Feb 2022

Study suggests hospitalized COVID-19 patients are at higher risk of neurocognitive decline

In a new study, scientists have evaluated patient-reported and clinically tested neuropsychological problems in both ambulatory (outpatients) and hospitalized COVID-19 patients during the early recovery phase.

8 Feb 2022

Fatigue News and Research

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

Heart attack survivors may have a lower risk of Parkinson's disease

COVID-Somnia: the relationship between COVID-19 and insomnia

Study describes sequelae presenting more than six months after COVID-19 in non-hospitalized young adults

How has telemedicine assisted COVID-19 patients?

Enhanced external counterpulsation therapy benefits long COVID-19 patients

Study explores the social impact of COVID-19 symptoms among female long haulers

Researchers identify autoantibody targets in COVID-19 patients

Looking into the long-COVID brain

Study examines the viral dynamics of Hong Kong's four SARS-CoV-2 waves

Only few oncology dietitians ask cancer patients about food insecurity, research finds

Hazards of persistent and new clinical sequelae caused by SARS-CoV-2 infection among elderly patients

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

KHN’s ‘What the Health?’: FDA takes center stage

Study: Almost a third of older adults infected with covid-19 develop new conditions

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

UCI case report: Antihistamines may provide relief for people suffering from long COVID-19 symptoms

Danish study of long COVID in teens

Toxic goiter affects the brain more than previously thought

Study suggests hospitalized COVID-19 patients are at higher risk of neurocognitive decline

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News